Gut Microbiota in Movement Disorders

Gut microbiota has been implicated in neurodevelopment, neuroinflammatory responses, and neurological disorders. Here is the latest research on the role of gut microbiota in movement disorders.

July 8, 2020
Open Access

Safety of Plasma Infusions in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Jordan E ParkerHelen M Bronte-Stewart
July 10, 2020

Progression and survival of patients with motor neuron disease relative to their fecal microbiota

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Shyuan T NgoFrederik J Steyn
July 22, 2020

Childbirth and Delayed Parkinson's Onset: A Reproducible Nonbiological Artifact of Societal Change

Movement Disorders : Official Journal of the Movement Disorder Society
Michael R MacAskillToni L Pitcher
July 22, 2020
Comment / Editorial

What Matters in Parkinson's Disease: Sex, Number of Children, or Birth Cohort?

Movement Disorders : Official Journal of the Movement Disorder Society
Rita A Popat, Lorene M Nelson
August 4, 2020

High γ-Aminobutyric Acid Content within the Medial Prefrontal Cortex Is a Functional Signature of Somatic Symptoms Disorder in Patients with Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Stefano Delli PizziLaura Bonanni
July 15, 2020

Mutation Analysis of DNAJC Family for Early-Onset Parkinson's Disease in a Chinese Cohort

Movement Disorders : Official Journal of the Movement Disorder Society
Chunyu LiHuifang Shang
July 11, 2020

CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Erika De FrancescoMarco Cosentino
July 18, 2020

Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Yongping ChenHuifang Shang
July 1, 2020
Open Access

Insulin Sensitivity in De Novo Parkinson's Disease: A Hyperinsulinemic-Euglycemic Clamp Study

Movement Disorders : Official Journal of the Movement Disorder Society
N Ahmad AzizHanno Pijl
July 21, 2020
Open Access

Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials

Movement Disorders : Official Journal of the Movement Disorder Society
Douglas R Langbehn, Steven Hersch
July 10, 2020
Open Access

Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study

Movement Disorders : Official Journal of the Movement Disorder Society
Ariel Fangting YingLouis C S Tan
July 12, 2020
Review

Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Geir BjørklundMichael Maes
July 22, 2020

Reply to: Exercise for "Sleep Rehabilitation" in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Amy W AmaraMarcas M Bamman
July 22, 2020
Comment / Editorial

Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?

Movement Disorders : Official Journal of the Movement Disorder Society
Henrik Zetterberg
July 4, 2020
Open Access

Wilson's Disease in Finland: A Nationwide Population-Based Study

Movement Disorders : Official Journal of the Movement Disorder Society
Jussi O T SipiläValtteri Kaasinen
July 19, 2020

Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Gaiying LiJianqi Li
July 15, 2020

Visual Impairment Is More Common in Parkinson's Disease and Is a Risk Factor for Poor Health Outcomes

Movement Disorders : Official Journal of the Movement Disorder Society
Ali G HamedaniAllison W Willis
August 4, 2020

Residual Injurious Symptoms and Its Association with Neurodegenerative Outcomes in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective, Longitudinal Follow-Up Study

Movement Disorders : Official Journal of the Movement Disorder Society
Jing WangYun Kwok Wing
July 10, 2020

Dopamine D1 Receptors Regulate Spines in Striatal Direct-Pathway and Indirect-Pathway Neurons

Movement Disorders : Official Journal of the Movement Disorder Society
Luz M SuarezRosario Moratalla
July 1, 2020
Review
Open Access

Integrated Care in Parkinson's Disease: A Systematic Review and Meta-Analysis

Movement Disorders : Official Journal of the Movement Disorder Society
Roopa RajanCarsten Eggers

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/gut-microbiota-in-movement-disorders/7ce8573c-14ce-4c0b-b390-6f3f6d30a962